MARKET

CRMD

CRMD

CORMEDIX
AMEX

Real-time Quotes | Nasdaq Last Sale

3.160
-0.430
-11.98%
After Hours: 3.155 -0.005 -0.16% 16:06 04/01 EDT
OPEN
3.420
PREV CLOSE
3.590
HIGH
3.460
LOW
3.070
VOLUME
197.37K
TURNOVER
--
52 WEEK HIGH
10.76
52 WEEK LOW
2.160
MARKET CAP
83.61M
P/E (TTM)
-1.7704
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CRMD stock price target is 12.00 with a high estimate of 14.00 and a low estimate of 10.00.

EPS

CRMD News

More
  • Edited Transcript of CRMD earnings conference call or presentation 16-Mar-20 8:30pm GMT
  • Thomson Reuters StreetEvents · 20h ago
  • CorMedix, Inc. (NYSEMKT:CRMD) Just Reported Earnings, And Analysts Cut Their Target Price
  • Simply Wall St. · 03/20 11:32
  • Editas Medicine (EDIT) Catches Eye: Stock Jumps 9%
  • Zacks · 03/19 15:40
  • What Did CorMedix, Inc.'s (NYSEMKT:CRMD) CEO Take Home Last Year?
  • Simply Wall St. · 03/19 12:19

Industry

Pharmaceuticals
-2.51%
Pharmaceuticals & Medical Research
-2.97%

Hot Stocks

Symbol
Price
%Change

About CRMD

CorMedix Inc. is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company has in-licensed the rights to develop and commercialize its product candidate, CRMD003 (Neutrolin), which addresses market opportunities in the instances in which a central venous catheter is used, such as hemodialysis, intensive care units, oncology, and patients receiving total parenteral nutrition, intravenous (IV) hydration, and/or IV medications. Neutrolin is an anti-infective solution for the prevention of catheter-related infections and thrombosis in the central venous catheter markets, such as dialysis, critical care and oncology. Neutrolin is a broad-spectrum antimicrobial/antifungal and anticoagulant combination that is active against common microbes, including antibiotic-resistant strains, and may prevent biofilm formation.
More

Webull offers kinds of CorMedix Inc. stock information, including AMEX:CRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRMD stock news, and many more online research tools to help you make informed decisions.